A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis - Dahlberg, L E; Aydemir, A; Muurahainen, N (Clin Exp Rheumatol, 2016)